Aurora Spine earned FDA 510(k) clearance for its Aero facet fusion system, the devicemaker said March 25.
Aero is a minimally invasive system for facet joint-related pain or instability in levels C2 to S1, according to a news release. It can be used as a standalone or as an adjunct to larger spinal fusions.
The first cases with the system are expected to take place in the third quarter of 2025.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
